NEW YORK (GenomeWeb) – NanoMolecular DX, a firm headed by Nuclea Biotechnologies' former Founder and CEO Patrick Muraca has agreed to purchase the bankrupt company's assets for $330,000.
NEW YORK (GenomeWeb) – NanoMolecular DX, a firm headed by Nuclea Biotechnologies' former Founder and CEO Patrick Muraca has agreed to purchase the bankrupt company's assets for $330,000.
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.